Hot penny stocks... don't get burned
   

News for Accentia Biopharmace (ABPI)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
News for Accentia Biopharmaceuticals Inc.  (ABPI) 
|
$ 0.3992      -0.0008 (-0.20%) Volume: 582.54 k 11:48 AM EDT Oct 7, 2008
Tue, Oct 07, 2008
11:16 AM Biovest Announces BiovaxID(R) Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44% - Business Wire
Fri, Sep 26, 2008
5:35 PM Accentia Biopharmaceuticals Receives NASDAQ Notice - Business Wire
Thu, Aug 14, 2008
5:41 PM Accentia Reports Fiscal Third Quarter Financial Results - Business Wire
Tue, Aug 05, 2008
9:42 AM Biovest Joins in the Formation of the Joint U.S.-Norway Cancer Research Program, a Collaborative Effort with Plans to Present to NCI and the U.S. Military Healthcare System - Business Wire
Mon, Jul 21, 2008
8:38 AM Biovest Announces Conference Call / Webcast to Discuss Phase 3 BiovaxID(R) Anti-Cancer Vaccine Results - Business Wire
Fri, Jul 18, 2008
9:20 AM BeaconEquity.com Issues TraderNotes on Active Stocks: MNLU, DELL, WAHCU, RUTH, ABPI, CATS - PR Newswire
Thu, Jul 17, 2008
11:29 AM Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial - Business Wire
10:45 AM Biovest Reports Results for Patients Treated with Anti-Cancer Vaccine: BiovaxID(R) Demonstrates Clinically and Statistically Significant Improvement of Disease-Free Survival in Non-Hodgkin's Lymphoma in Pivotal Phase 3 Clinical Trial - Business Wire
Mon, Jun 23, 2008
4:03 PM Accentia Biopharmaceuticals to Present at the Jefferies Second Annual Healthcare Conference - Business Wire
Wed, Jun 18, 2008
8:59 AM Davita spent $1.2 million lobbying in 1Q and RXi Pharmaceuticals to Present at the 2008 BIO International Convention - U.S. Equity News
Tue, Jun 17, 2008
1:31 PM Accentia Reports on Multiple Sclerosis Study: Revimmune(R) Shows Unprecedented Results in Reducing Disability and Improving Functions - Business Wire
10:39 AM Accentia Biopharmaceuticals Announces $8.5 Million Financing to Advance Key Strategies for SinuNase(TM) and Revimmune(TM) - Business Wire
Thu, Jun 12, 2008
3:00 AM BeaconEquity.com Issues Trader Notes on BCFT, ABPI, AGU, MCHP, DSCO, AMAT, NVDA, SPLS - PR Newswire
Wed, Jun 11, 2008
7:08 AM Biovest Reports Blinded Results for Phase 3 Study Evaluating Anti-Cancer Vaccine, BiovaxID(R), which Shows 100% Difference in Disease-Free Survival at 36 Months in the Comparative Arms - Business Wire

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for ABPI stock. Download ABPI report.
Research Report
Get the full report for FREE
Date:Sep 2, 2008
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download ABPI report
  
Example preview: Research report for Accentia Biopharmace (ABPI) Research report for Accentia Biopharmace (ABPI) Research report for Accentia Biopharmace (ABPI) Research report for Accentia Biopharmace (ABPI)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

Hot Green Energy Stock from China


From: OTC Journal
Added: 16 Sep, 2008

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Accentia Biopharmace
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.